home / stock / rvph / rvph news


RVPH News and Press, Reviva Pharmaceuticals Holdings Inc. From 01/10/24

Stock Information

Company Name: Reviva Pharmaceuticals Holdings Inc.
Stock Symbol: RVPH
Market: NASDAQ
Website: revivapharma.com

Menu

RVPH RVPH Quote RVPH Short RVPH News RVPH Articles RVPH Message Board
Get RVPH Alerts

News, Short Squeeze, Breakout and More Instantly...

RVPH - Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

CUPERTINO, CA / ACCESSWIRE / January 10, 2024 / Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardio...

RVPH - Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

– Schizophrenia late-stage clinical program advances with positive topline Phase 3 data, successful ongoing enrollment in open label extension (OLE) trial, and positive drug-drug interaction data supporting a differentiated profile for once-daily brilaroxazine – – I...

RVPH - 24/7 Market News Lunch Break 22 Dec 2023

2023-12-22 12:23:57 ET DENVER, Colo., Dec. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Royalty Management Holding Corp (NASDAQ: RMCO), Senti Biosciences Inc (NASDAQ: SNTI), Polished.com Inc...

RVPH - Life Science Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Investor Forum sponsored by Zacks Small-Cap Research. held December 14 th are now available for online viewing....

RVPH - Life Science Investor Forum Agenda Announced for December 14th, 2023

NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum to be held December 14 th . This event is sponsored by Zacks Small-Cap Research. Individual investors, i...

RVPH - Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

CUPERTINO, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...

RVPH - AbbVie - Cerevel M&A deal lifts Reviva, Karuna

2023-12-07 08:47:08 ET More on Karuna, Reviva, etc. Karuna Therapeutics: Rewiring The Schizophrenia Paradigm - A Novel Leap Beyond Dopamine Karuna Therapeutics, Inc. (KRTX) Q3 2023 Earnings Conference Call Transcript Reviva Pharmaceuticals: Positive Results In Phase ...

RVPH - VTGN, CERE and RVPH are among pre market gainers

2023-12-07 08:27:08 ET MicroAlgo  ( MLGO ) +74% plans to establish a practice base to train graduate students for the university. Altisource Asset Management  ( AAMC ) +23% Asset case against six defendants in suit v. BlackRock, Pimco can proceed. ...

RVPH - Reviva Pharmaceuticals to Participate in The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

CUPERTINO, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...

RVPH - Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CUPERTINO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous...

Previous 10 Next 10